Ghaleb Darwazeh, MD
Vascular Surgery · Loma Linda, CANPI 1326320003
Payments from drug & device makers
Across 77 payments — averaging $121.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Penumbra, Inc.$3K
- W. L. Gore & Associates, Inc.$2K
- Silk Road Medical, Inc.$2K
- Acera Surgical, Inc.$209
- Terumo Medical Corporation$68
- plus $389 from 11 others
What the payments were for
- Travel & lodging$6,49069%
- Food & beverage$2,88931%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 33 | $3,114 |
| Penumbra, Inc. | 6 | $2,539 |
| W. L. Gore & Associates, Inc. | 13 | $1,548 |
| Silk Road Medical, Inc. | 5 | $1,510 |
| Acera Surgical, Inc. | 2 | $209 |
| Terumo Medical Corporation | 3 | $68 |
| Cook Medical LLC | 3 | $62 |
| Boston Scientific | 2 | $57 |
| Imperative Care, Inc | 2 | $46 |
| Innovation Technologies Inc | 1 | $44 |
| Philips North America LLC | 1 | $35 |
| Bard Peripheral Vascular, Inc. | 1 | $33 |
| Mimedx Group, Inc. | 1 | $31 |
| Shape Memory Medical Inc. | 1 | $26 |
| Stryker | 1 | $23 |
| Bolton Medical Inc | 1 | $17 |
| Lemaitre Vascular, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$2,417
- ENROUTE Transcarotid Stent$1,486
- ENROUTE Transcarotid Neuroprotection System$1,486
- VenaSeal$1,266
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$973
- ENDURANT IIS$540
- Restrata Wound Matrix$185
- Abre$176
- Valiant Captivia$171
- GORE VIABAHN VBX Balloon Expandable Endo$166
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$130
How this compares
$9,379 in reported general payments places this provider in the 65th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 22 | $112 |
| Atorvastatin Calcium | 15 | $42 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Loma Linda
- Allen MurgaLoma Linda$81K
- Venita ChandraPalo Alto$947K
- Leigh Ann ObanionFresno$932K
- Sukgu HanLos Angeles$765K
- Mahmoud Malasla Jolla$508K
- Son DuongFountain Valley$503K
- Leo FongClovis$496K
- Jason LeePalo Alto$403K
- Bernardo Curi MendesLos Angeles$376K
- Trevor DerderianRancho Mirage$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.